These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 1956956)

  • 1. The genetic and biochemical basis of polyketide metabolism in microorganisms and its role in drug discovery and development.
    Hutchinson CR; Borell CW; Donovan MJ; Kato F; Motamedi H; Nakayama H; Rubin RL; Streicher SL; Summers RG; Wendt-Pienkowski E
    Planta Med; 1991 Oct; 57(7):S36-43. PubMed ID: 1956956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetic and biochemical basis of polyketide metabolism in microorganisms and its role in drug discovery and development.
    Hutchinson CR; Borell CW; Donovan MJ; Kato F; Motamedi H; Nakayama H; Rubin RL; Streicher SL; Summers RG; Wendt-Pienkowski E; Wessel WL
    Planta Med; 1991 Oct; 57(7 Suppl):S36-43. PubMed ID: 17226221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design of aromatic polyketide natural products by recombinant assembly of enzymatic subunits.
    McDaniel R; Ebert-Khosla S; Hopwood DA; Khosla C
    Nature; 1995 Jun; 375(6532):549-54. PubMed ID: 7791871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered biosynthesis of geldanamycin analogs for Hsp90 inhibition.
    Patel K; Piagentini M; Rascher A; Tian ZQ; Buchanan GO; Regentin R; Hu Z; Hutchinson CR; McDaniel R
    Chem Biol; 2004 Dec; 11(12):1625-33. PubMed ID: 15610846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering of avermectin biosynthetic genes to improve production of ivermectin in Streptomyces avermitilis.
    Li M; Chen Z; Lin X; Zhang X; Song Y; Wen Y; Li J
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5359-63. PubMed ID: 18824353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for dealing with reactive intermediates in drug discovery and development.
    Nassar AE; Lopez-Anaya A
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):126-36. PubMed ID: 14982156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploiting marine actinomycete biosynthetic pathways for drug discovery.
    Moore BS; Kalaitzis JA; Xiang L
    Antonie Van Leeuwenhoek; 2005 Jan; 87(1):49-57. PubMed ID: 15726291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of molecular biology on drug discovery.
    Belfield GP; Delaney SJ
    Biochem Soc Trans; 2006 Apr; 34(Pt 2):313-6. PubMed ID: 16545102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biosynthes of polyketide antibiotics by various actinomycin producing Streptomyces species].
    Alekhova TA; Novozhilova TIu
    Prikl Biokhim Mikrobiol; 2001; 37(3):309-16. PubMed ID: 11443900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterologous biosynthesis of truncated hexaketides derived from the actinorhodin polyketide synthase.
    Kalaitzis JA; Moore BS
    J Nat Prod; 2004 Aug; 67(8):1419-22. PubMed ID: 15332868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of high throughput screening in the early stage of drug research].
    Keserü GM
    Acta Pharm Hung; 2004; 74(1):5-10. PubMed ID: 15524043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of 8-demethylgeldanamycin and 4,5-epoxy-8-demethylgeldanamycin from a recombinant strain of Streptomyces hygroscopicus.
    Buchanan GO; Regentin R; Piagentini M; Rascher A; McDaniel R; Galazzo JL; Licari PJ
    J Nat Prod; 2005 Apr; 68(4):607-10. PubMed ID: 15844961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural product hybrids as new leads for drug discovery.
    Tietze LF; Bell HP; Chandrasekhar S
    Angew Chem Int Ed Engl; 2003 Sep; 42(34):3996-4028. PubMed ID: 12973759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical formulations for discovery and toxicology: physicochemical challenges.
    Neervannan S
    Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):715-31. PubMed ID: 17014391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translational strategies for development of monoclonal antibodies from discovery to the clinic.
    Tabrizi MA; Bornstein GG; Klakamp SL; Drake A; Knight R; Roskos L
    Drug Discov Today; 2009 Mar; 14(5-6):298-305. PubMed ID: 19152840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered biosynthesis of 16-membered macrolides that require methoxymalonyl-ACP precursors in Streptomyces fradiae.
    Rodriguez E; Ward S; Fu H; Revill WP; McDaniel R; Katz L
    Appl Microbiol Biotechnol; 2004 Nov; 66(1):85-91. PubMed ID: 15179529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caenorhabditis elegans: a versatile platform for drug discovery.
    Artal-Sanz M; de Jong L; Tavernarakis N
    Biotechnol J; 2006 Dec; 1(12):1405-18. PubMed ID: 17109493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering biosynthetic pathways for deoxysugars: branched-chain sugar pathways and derivatives from the antitumor tetracenomycin.
    Lombó F; Gibson M; Greenwell L; Braña AF; Rohr J; Salas JA; Méndez C
    Chem Biol; 2004 Dec; 11(12):1709-18. PubMed ID: 15610855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular imaging strategies for drug discovery and development.
    Gross S; Piwnica-Worms D
    Curr Opin Chem Biol; 2006 Aug; 10(4):334-42. PubMed ID: 16822702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterologous expression and genetic engineering of the phenalinolactone biosynthetic gene cluster by using red/ET recombineering.
    Binz TM; Wenzel SC; Schnell HJ; Bechthold A; Müller R
    Chembiochem; 2008 Feb; 9(3):447-54. PubMed ID: 18157854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.